Form 4: Quanterix Director Walt Boosts Stake with Stock Grant

Quanterix Director David R. Walt acquired 2,594 shares of common stock on October 1, 2025, as compensation for his board service.

Summary

• Director David R. Walt acquired 2,594 shares of Quanterix Corp (QTRX) common stock.
• The transaction occurred on October 1, 2025, at a price of $5.54 per share.
• The shares were granted in lieu of cash fees for service on the Company's Board of Directors and its committees for the third quarter of 2025.
• Following this transaction, David R. Walt beneficially owns a total of 1,871,675 shares, which includes 7,435 restricted stock units.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as compensation, generally indicates alignment of interests with shareholders and confidence in the company's future, which is a moderately positive signal.

Positives

• The acquisition of additional shares by a director, even as compensation, aligns management's interests with those of shareholders, potentially signaling confidence in the company's future performance.

Industry Context

This transaction is a routine insider filing for a director of a publicly traded company in the life sciences and diagnostics sector. Such compensation practices are common across industries, reflecting a trend towards aligning executive and board incentives with shareholder value through equity grants.

Related Party Transactions

• Stock granted to Director David R. Walt in lieu of cash fees for service on the Company's Board of Directors and its committees for the third quarter of 2025.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a positive sign of commitment and alignment with long-term company performance.

Key Dates

Keywords

Quanterix, QTRX, Insider Trading, Form 4, Director Compensation, Stock Grant, Biotech, Diagnostics